What is the future for surgical oncology?

by Thompson, A M
Published 2011

p53-Based cyclotherapy: exploiting the ‘guardian of the genome' to protect normal cells from cytotoxic therapy

by Rao, B, Lain, S, Thompson, A M
Published 2013

Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.

by Thompson, A. M., Kerr, D. J., Steel, C. M.
Published 1991

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.

by Thompson, A. M., Elton, R. A., Hawkins, R. A., Chetty, U., Steel, C. M.
Published 1998

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.

by Hubbard, A. L., Doris, C. P., Thompson, A. M., Chetty, U., Anderson, T. J.
Published 1994

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

by Makubate, B, Donnan, P T, Dewar, J A, Thompson, A M, McCowan, C
Published 2013

The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study

by McCowan, C, Wang, S, Thompson, A M, Makubate, B, Petrie, D J
Published 2013

Reduction in gastric cancer surgical mortality over 10 years: An adverse events analysis

by Young, J.A., Shimi, S.M., Kerr, L., McPhillips, G., Thompson, A.M.
Published 2014

Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study

by Fraser, D M, Sullivan, F M, Thompson, A M, McCowan, C
Published 2014

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up...

by Thompson, A. M., Crichton, D. N., Elton, R. A., Clay, M. F., Chetty, U., Steel, C. M.
Published 1998

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.

by Prosser, J., Porter, D., Coles, C., Condie, A., Thompson, A. M., Chetty, U., Steel, C. M., Evans, H. J.
Published 1992

Expression of transforming growth factor beta mRNA isoforms in human breast cancer.

by MacCallum, J., Bartlett, J. M., Thompson, A. M., Keen, J. C., Dixon, J. M., Miller, W. R.
Published 1994

pS2 is an independent factor of good prognosis in primary breast cancer.

by Thompson, A. M., Hawkins, R. A., Elton, R. A., Steel, C. M., Chetty, U., Carter, D. C.
Published 1993

Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.

by Thompson, A. M., Morris, R. G., Wallace, M., Wyllie, A. H., Steel, C. M., Carter, D. C.
Published 1993

Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy.

by MacCallum, J., Keen, J. C., Bartlett, J. M., Thompson, A. M., Dixon, J. M., Miller, W. R.
Published 1996

Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer

by Bruce, J, Thornton, A J, Scott, N W, Marfizo, S, Powell, R, Johnston, M, Wells, M, Heys, S D, Thompson, A M
Published 2012

Lack of correlation of stem cell markers in breast cancer stem cells

by Liu, Y, Nenutil, R, Appleyard, M V, Murray, K, Boylan, M, Thompson, A M, Coates, P J
Published 2014

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study

by Purdie, C A, Quinlan, P, Jordan, L B, Ashfield, A, Ogston, S, Dewar, J A, Thompson, A M
Published 2014

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.

by Thompson, A. M., Steel, C. M., Chetty, U., Hawkins, R. A., Miller, W. R., Carter, D. C., Forrest, A. P., Evans, H. J.
Published 1990

Gene expression in oestrogen-dependent human breast cancer xenograft tumours.

by Thompson, A. M., Steel, C. M., Foster, M. E., Kerr, D., Paterson, D., Deane, D., Hawkins, R. A., Carter, D. C., Evans, H. J.
Published 1990